Peripheral challenge with a viral mimic upregulates expression of the complement genes in the hippocampus

Journal of Neuroimmunology

Volumn 285, Issue , 2015, Pages 137-142

  Michalovicz, Lindsay T ^a   Lally, Brent ^a   Konat, Gregory W ^a  

^a WEST VIRGINIA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Complement system; Hippocampus; Immunofluorescence; Inflammation; Polyinosinic polycytidylic acid; Transcriptome

Indexed keywords

ALTERNATIVE COMPLEMENT PATHWAY C3 C5 CONVERTASE; COMPLEMENT; POLYINOSINIC POLYCYTIDYLIC ACID; TRANSCRIPTOME; ANTIVIRUS AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOINFORMATICS; COMPLEMENT FACTOR B GENE; COMPLEMENT GENE; CONTROLLED STUDY; GENE ACTIVATION; GENE EXPRESSION REGULATION; GENETIC ANALYSIS; HIPPOCAMPAL HYPEREXCITABILITY; HIPPOCAMPUS; MOUSE; NERVE EXCITABILITY; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; ANIMAL; C57BL MOUSE; COMPLEMENT ACTIVATION; DRUG EFFECTS; MOLECULAR MIMICRY; PHYSIOLOGY;

ANIMALS; ANTIVIRAL AGENTS; COMPLEMENT ACTIVATION; GENE EXPRESSION REGULATION; HIPPOCAMPUS; MICE; MICE, INBRED C57BL; MOLECULAR MIMICRY; POLY I-C; UP-REGULATION;

EID: 84943231804     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2015.06.003     Document Type: Article

References (49)

1. Bae J.S., Simon N.G., Menon P., Vucic S., Kiernan M.C. The puzzling case of hyperexcitability in amyotrophic lateral sclerosis. J. Clin. Neurol. 2013, 9:65-74.
2. Ben-Ari Y., Cossart R. Kainate, a double agent that generates seizures: two decades of progress. Trends Neurosci. 2000, 23:580-587.
3. Buljevac D., Flach H.Z., Hop W.C., Hijdra D., Laman J.D., Savelkoul H.F., van Der Meche F.G., van Doorn P.A., Hintzen R.Q. Prospective study on the relationship between infections and multiple sclerosis exacerbations. Brain 2002, 125:952-960.
4. Caramia M.D., Palmieri M.G., Desiato M.T., Boffa L., Galizia P., Rossini P.M., Centonze D., Bernardi G. Brain excitability changes in the relapsing and remitting phases of multiple sclerosis: a study with transcranial magnetic stimulation. Clin. Neurophysiol. 2004, 115:956-965.
5. Carmichael S.T. Plasticity of cortical projections after stroke. Neuroscientist 2003, 9:64-75.
6. Dantzer R. Cytokine, sickness behavior, and depression. Neurol. Clin. 2006, 24:441-460.
7. Dantzer R., Kelley K.W. Twenty years of research on cytokine-induced sickness behavior. Brain Behav. Immun. 2007, 21:153-160.
8. Denes A., Ferenczi S., Kovacs K.J. Systemic inflammatory challenges compromise survival after experimental stroke via augmenting brain inflammation, blood-brain barrier damage and brain oedema independently of infarct size. J. Neuroinflammation 2011, 8:164.
9. Dennis G., Sherman B.T., Hosack D.A., Yang J., Gao W., Lane H.C., Lempicki R.A. DAVID: database for annotation, visualization, and integrated discovery. Genome Biol. 2003, 4:3.
10. Draghici S., Khatri P., Tarca A.L., Amin K., Done A., Voichita C., Georgescu C., Romero R. A systems biology approach for pathway level analysis. Genome Res. 2007, 17:1537-1545.
11. Edwards S., Zvartau M., Clarke H., Irving W., Blumhardt L.D. Clinical relapses and disease activity on magnetic resonance imaging associated with viral upper respiratory tract infections in multiple sclerosis. J. Neurol. Neurosurg. Psychiatry 1998, 64:736-741.
12. Elvington A., Atkinson C., Zhu H., Yu J., Takahashi K., Stahl G.L., Kindy M.S., Tomlinson S. The alternative complement pathway propagates inflammation and injury in murine ischemic stroke. J. Immunol. 2012, 189:4640-4647.
13. Ferrari C.C., Tarelli R. Parkinson's disease and systemic inflammation. Parkinsons Dis. 2011, 2011:436813.
14. Field R., Campion S., Warren C., Murray C., Cunningham C. Systemic challenge with the TLR3 agonist poly I:C induces amplified IFNalpha/beta and IL-1beta responses in the diseased brain and exacerbates chronic neurodegeneration. Brain Behav. Immun. 2010, 24:996-1007.
15. Fil D., Borysiewicz E., Konat G.W. A broad upregulation of cerebral chemokine genes by peripherally-generated inflammatory mediators. Metab. Brain Dis. 2011, 26:49-59.
16. Holmes C., El-Okl M., Williams A.L., Cunningham C., Wilcockson D., Perry V.H. Systemic infection, interleukin 1beta, and cognitive decline in Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 2003, 74:788-789.
17. Huynh W., Krishnan A.V., Vucic S., Lin C.S., Kiernan M.C. Motor cortex excitability in acute cerebellar infarct. Cerebellum 2013, 12:826-834.
18. Ikoma K., Mano Y., Takayanagi T. Pulsed magnetic stimulation and F waves in Parkinson's disease. Intern. Med. 1994, 33:77-81.
19. Ilschner S., Nolte C., Kettenmann H. Complement factor C5a and epidermal growth factor trigger the activation of outward potassium currents in cultured murine microglia. Neuroscience 1996, 73:1109-1120.
20. Ji K., Miyauchi J., Tsirka S.E. Microglia: an active player in the regulation of synaptic activity. Neural Plast. 2013, 2013:627325.
21. Kettenmann H., KirchhoffF., Verkhratsky A. Microglia: new roles for the synaptic stripper. Neuron 2013, 77:10-18.
22. Khedr E.M., Ahmed M.A., Darwish E.S., Ali A.M. The relationship between motor cortex excitability and severity of Alzheimer's disease: a transcranial magnetic stimulation study. Neurophysiol. Clin. 2011, 41:107-113.
23. Kirschman L.T., Borysiewicz E., Fil D., Konat G.W. Peripheral immune challenge with dsRNA enhances kainic acid-induced status epilepticus. Metab. Brain Dis. 2011, 26:91-93.
24. Kitazawa M., Oddo S., Yamasaki T.R., Green K.N., LaFerla F.M. Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. J. Neurosci. 2005, 25:8843-8853.
25. Konat G.W., Borysiewicz E. Cerebellar expression of inflammatory genes triggered by peripheral challenge with dsRNA. J. Neurochem. 2009, 108(Suppl. 1):133.
26. Konat G.W., Borysiewicz E., Fil D., James I. Peripheral challenge with double-stranded RNA elicits global up-regulation of cytokine gene expression in the brain. J. Neurosci. Res. 2009, 87:1381-1388.
27. Krasowska-Zoladek A., Banaszewska M., Kraszpulski M., Konat G.W. Kinetics of inflammatory response of astrocytes induced by TLR 3 and TLR4 ligation. J. Neurosci. Res. 2007, 85:205-212.
28. Lenczowski M.J., Van Dam A.M., Poole S., Larrick J.W., Tilders F.J. Role of circulating endotoxin and interleukin-6 in the ACTH and corticosterone response to intraperitoneal LPS. Am. J. Physiol. 1997, 273:R1870-R1877.
29. Machado A., Herrera A.J., Venero J.L., Santiago M., de Pablos R.M., Villaran R.F., Espinosa-Oliva A.M., Arguelles S., Sarmiento M., Delgado-Cortes M.J., Maurino R., Cano J. Peripheral inflammation increases the damage in animal models of nigrostriatal dopaminergic neurodegeneration: possible implication in Parkinson's disease incidence. Parkinsons Dis. 2011, 2011:393769.
30. McNamara J.O. Emerging insights into the genesis of epilepsy. Nature 1999, 399:A15-A22.
31. Michalovicz L.T., Konat G.W. Peripherally restricted acute phase response to a viral mimic alters hippocampal gene expression. Metab. Brain Dis. 2014, 29:75-86.
32. Murray C.L., Skelly D.T., Cunningham C. Exacerbation of CNS inflammation and neurodegeneration by systemic LPS treatment is independent of circulating IL-1beta and IL-6. J. Neuroinflammation 2011, 8:50.
33. Nardone R., Bergmann J., Kunz A., Caleri F., Seidl M., Tezzon F., Gerstenbrand F., Trinka E., Golaszewski S. Cortical excitability changes in patients with sleep-wake disturbances after traumatic brain injury. J. Neurotrauma 2011, 28:1165-1171.
34. Nguyen M.D., D'Aigle T., Gowing G., Julien J.P., Rivest S. Exacerbation of motor neuron disease by chronic stimulation of innate immunity in a mouse model of amyotrophic lateral sclerosis. J. Neurosci. 2004, 24:1340-1349.
35. Patel S., Lyons-Weiler J. caGEDA: a web application for the integrated analysis of global gene expression patterns in cancer. Appl. Bioinforma. 2004, 3:49-62.
36. Quan N., Banks W.A. Brain-immune communication pathways. Brain Behav. Immun. 2007, 21:727-735.
37. Ren X., Zhou H., Li B., Su S.B. Toll-like receptor 3 ligand polyinosinic:polycytidylic acid enhances autoimmune disease in a retinal autoimmunity model. Int. Immunopharmacol. 2011, 11:769-773.
38. Romanovsky A.A., Ivanov A.I., Lenczowski M.J., Kulchitsky V.A., Van Dam A.M., Poole S., Homer L.D., Tilders F.J. Lipopolysaccharide transport from the peritoneal cavity to the blood: is it controlled by the vagus nerve?. Auton. Neurosci. 2000, 85:133-140.
39. Rossi S., Furlan R., De C V., Motta C., Studer V., Mori F., Musella A., Bergami A., Muzio L., Bernardi G., Battistini L., Martino G., Centonze D. Interleukin-1beta causes synaptic hyperexcitability in multiple sclerosis. Ann. Neurol. 2012, 71:76-83.
40. Schafer D.P., Lehrman E.K., Kautzman A.G., Koyama R., Mardinly A.R., Yamasaki R., RansohoffR.M., Greenberg M.E., Barres B.A., Stevens B. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron 2012, 74:691-705.
41. Serres S., Anthony D.C., Jiang Y., Broom K.A., Campbell S.J., Tyler D.J., van Kasteren S.I., Davis B.G., Sibson N.R. Systemic inflammatory response reactivates immune-mediated lesions in rat brain. J. Neurosci. 2009, 29:4820-4828.
42. Stephan A.H., Madison D.V., Mateos J.M., Fraser D.A., Lovelett E.A., Coutellier L., Kim L., Tsai H.H., Huang E.J., Rowitch D.H., Berns D.S., Tenner A.J., Shamloo M., Barres B.A. A dramatic increase of C1q protein in the CNS during normal aging. J. Neurosci. 2013, 33:13460-13474.
43. Stevens B., Allen N.J., Vazquez L.E., Howell G.R., Christopherson K.S., Nouri N., Micheva K.D., Mehalow A.K., Huberman A.D., Stafford B., Sher A., Litke A.M., Lambris J.D., Smith S.J., John S.W., Barres B.A. The classical complement cascade mediates CNS synapse elimination. Cell 2007, 131:1164-1178.
44. Strohmeyer R., Shen Y., Rogers J. Detection of complement alternative pathway mRNA and proteins in the Alzheimer's disease brain. Brain Res. Mol. Brain Res. 2000, 81:7-18.
45. Terai K., Walker D.G., McGeer E.G., McGeer P.L. Neurons express proteins of the classical complement pathway in Alzheimer disease. Brain Res. 1997, 769:385-390.
46. Thomson C.A., McColl A., Cavanagh J., Graham G.J. Peripheral inflammation is associated with remote global gene expression changes in the brain. J. Neuroinflammation 2014, 11:73.
47. Yousuf S., Atif F., Sayeed I., Wang J., Stein D.G. Post-stroke infections exacerbate ischemic brain injury in middle-aged rats: immunomodulation and neuroprotection by progesterone. Neuroscience 2013, 239:92-102.
48. Zhang R., Miller R.G., Gascon R., Champion S., Katz J., Lancero M., Narvaez A., Honrada R., Ruvalcaba D., McGrath M.S. Circulating endotoxin and systemic immune activation in sporadic amyotrophic lateral sclerosis (sALS). J. Neuroimmunol. 2009, 206:121-124.
49. Zhang J., Malik A., Choi H.B., Ko R.W., Dissing-Olesen L., MacVicar B.A. Microglial CR3 activation triggers long-term synaptic depression in the hippocampus via NADPH oxidase. Neuron 2014, 82:195-207.